Truist Financial
PJP icon

Truist Financial’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Truist Financial’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28,343
Closed -$2.94M – 2989
2026
Q1 		$2.94M Buy
+28,343
New +$2.99M ﹤0.01% 1104
2021
Q1 		– Sell
-3,040
Closed -$217K – 2711
2020
Q4 		$217K Sell
3,040
-946
-24% -$63.3K ﹤0.01% 2348
2020
Q3 		$254K Buy
3,986
+668
+20% +$43.7K ﹤0.01% 2133
2020
Q2 		$214K Buy
+3,318
New +$206K ﹤0.01% 2151

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Truist Financial's PJP Position: Q2 2026 in Review

Truist Financial sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2026, closing a stake of 28,343 shares — an estimated $2.94M sold.

Truist Financial first reported a position in PJP in Q2 2020 and held it in 4 quarters. The position peaked at $2.94M in Q1 2026. 116 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Truist Financial reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
  • Truist Financial sold 28,343 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $2.94M.
  • Truist Financial first reported a position in Invesco Pharmaceuticals ETF in Q2 2020 and held it in 4 quarters.
  • Truist Financial's Invesco Pharmaceuticals ETF position peaked at $2.94M in Q1 2026.
  • 116 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.